Your browser doesn't support javascript.
loading
Efficacy and safety of sotrovimab for vaccinated or unvaccinated patients with mild-to-moderate COVID-19 in the omicron era.
Izumo, Takehiro; Awano, Nobuyasu; Kuse, Naoyuki; Sakamoto, Keita; Takada, Kohei; Muto, Yutaka; Fujimoto, Kazushi; Saiki, Ayae; Ito, Yu; Ota, Hiroaki; Inomata, Minoru.
Afiliação
  • Izumo T; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Awano N; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Kuse N; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Sakamoto K; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Takada K; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Muto Y; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Fujimoto K; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Saiki A; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Ito Y; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Ota H; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
  • Inomata M; Department of Respiratory Medicine, Japanese Red Cross Medical Center, Tokyo, Japan.
Drug Discov Ther ; 16(3): 124-127, 2022 Jul 20.
Article em En | MEDLINE | ID: mdl-35753770
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas Virais / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article